Covid vaccine pause is blow to Oxford Biomedica - The Times
4/20/2022 12:00:00 AM3 years 10 months ago
by Alex Ralph
by Alex Ralph
Oxford Biomedica, one of Britain’s leading biotech companies, has warned of lower revenues and losses this year as manufacturing of the Oxford-AstraZeneca coronavirus vaccine is paused and it absorbs the cost of expanding in the United States.In a mixed outlo…
The chairman of Oxford Biomedica emphasised yesterday that it expected to strike a new Covid vaccine supply agreement with AstraZeneca after revealing that manufacturing had been paused. Alongside w… [+559 chars]
full article...